Clifford Chance has advised Keymed Biosciences (Chengdu) Co., Ltd. on the deal. Keymed Biosciences (Chengdu) Co., Ltd. completed an out-licensing transaction with Belenos Biosciences, Inc.to exclusively...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Essity AB on the deal. Linklaters acted for Royal Golden Eagle. Isola Castle Ltd, a company indirectly wholly owned by Asia Pacific Resources...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett is representing XPENG Inc. in the deal, Clifford Chance is advising Volkswagen Group. Volkswagen Group announced it has executed a strategic minority investment...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised CVC Capital Partners. CVC Capital Partners (CVC) agreed for its buyout of Xi’an Yikang Pharmacy. Yikang Pharmacy is a leading pharmaceutical retail...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised China Three Gorges (Europe) S.A. on the deal while King & Wood Mallesons has advised EDPR. China Three Gorges (Europe) S.A. (CTGE)...
You must be a Standard 1 Year member to access this content.
